JOURNAL 1483


Bioorganic & Medicinal Chemistry Reports
VOLUME & ISSUE
Year: 2019 Issue: 1-2 (January-December)
PAGES
p.24 - 31
STATISTICS
Viewed 764 times.
AUTHORS
  • Gökalp Çetin
  • Rahime Şimşek
PDF OF ARTICLE

GRAPHICAL ABSTRACT


ABSTRACT


It is known that microorganisms develop resistance to the drugs used in the treatment of diseases caused by bacteria and fungi. Therefore, the discovery of new drug molecules have great importance for the treatment of these diseases. In this study, compounds having dialkyl 4,4'-(1,4-phenylene)bis(2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate) general structure which are expected to exhibit antibacterial and antifungal activity were synthesized. 1H-NMR and IR analyzes were performed to prove their structures. All compounds were tested against Gram (+) Staphylococcus aureus and Gram (-) Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa to evaluate their in vitro antibacterial activity; Candida albicans and Cryptococcus neoformans var. grubii to evaluate in vitro antifungal activity. According to the biological activity data, the most active derivative in the series was compound 2 as an antibacterial agent and compound 7 as an antifungal agent.

KEYWORDS
  • hexahydroquinoline
  • Hantzsch synthesis
  • antibacterial
  • antifungal
  • inhibition